ipratropium bromide monohydrate

Spain

Drugs containing this active substance

  • IPRATROPIUM BROMIDE/SALBUTAMOL GENETIC 0.5 MG/2.5 MG SOLUTION FOR INHALATION BY NEBULIZER

    It is used to facilitate breathing in patients over 12 years of age with chronic obstructive pulmonary disease (COPD), helping to relieve wheezing, shortness of breath, and chest tightness.

    Form: solution for inhalation by nebulizer

    Active substance Dosage
    ipratropium bromide monohydrate 0,52 mg
    salbutamol sulfate 3 mg

    ATC: R03A R03AL R03AL02

    Manufacturer: Genetic S.P.A.